About 200 reports

  • 3.4.3 Forecast Assumptions and Methods - One-Year Total Prevalent Cases of POUD
  • Risk Factors and Comorbid Conditions Associated with OUD

The Han study provided the data for one-year total prevalence of DSM-IV opioid dependence.

  • Epidemiology
  • Hospital
  • Opioid
  • United States
  • Forecast

Opioid Drugs: Global Markets to 2023 Chapter ## Introduction Study Goals and Objectives Reasons for Doing This Study Scope of Report Information Sources Methodology Geographic Breakdown Analyst’s Credentials BCC Custom Research Related BCC Research Reports Chapter ## Summary and High

  • Opioid
  • Therapy
  • World
  • Market Shares
  • OPIOID ANTAGONISTS
  • Opioid Withdrawal Syndrome and Opioid Use Disorder Patient Populations

" One of the symptoms is opioid withdrawal.

  • Opioid
  • Therapy
  • United States
  • Forecast
  • Omeros Corporation

Global Opioids Drug Market Forecast 2019-2027 ##.

  • Opioid
  • Pharmaceutical
  • Therapy
  • World

GLOBAL NON-OPIOID PAIN TREATMENT MARKET FORECAST 2018-2026 ##.

  • Opioid
  • Therapy
  • World
  • Forecast
  • Market Size

Non-opioid Pain Treatment: Global Markets to 2022 Chapter ##: Introduction ## Study Goals and Objectives ## Reasons for Doing This Study ## Scope of Report ## Information Sources ## Methodology ## Geographic Breakdown ## Analyst’s Credentials ## Related B

  • Analgesic
  • Opioid
  • Therapy
  • World
  • Market Shares

Medical Marijuana and the Opioid Crisis Chapter ## Medical Marijuana and the Opioid Crisis What Are Cannabinoids and How Are They Related to Medical Marijuana?

  • Marijuana
  • Opioid
  • Recreational Activity
  • United States
  • Market Size

EUROPE OPIOIDS DRUG MARKET FORECAST 2019-2027 ##.

  • Opioid
  • Pharmaceutical
  • Therapy
  • Europe
  • Forecast

ASIA PACIFIC OPIOIDS DRUG MARKET FORECAST 2019-2027 ##.

  • Opioid
  • Pharmaceutical
  • Therapy
  • APAC
  • Forecast

NORTH AMERICA OPIOIDS DRUG MARKET FORECAST 2019-2027 ##.

  • Opioid
  • Pharmaceutical
  • Therapy
  • North America

Non-opioid Pain Patch Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024 ##.

  • Opioid
  • Pharmaceutical
  • Therapy
  • World
  • Forecast
  • A COMPARISON OF OPIOID AND NON-OPIOID DRUGS
  • PRIMARY ROUTES OF OPIOID ABUSE

ZACHAROFF, THIS COULD BE ONE OF THE PRIMARY REASONS FOR THE OPIOID EPIDEMIC. ##. ##. ##. ##.

  • Opioid
  • North America
  • United States
  • Eli Lilly & Co.
  • Grunenthal GmbH

Opioids Market Size, Share & Trends Analysis Report By Product, By Application, By Region And Segment Forecasts, 2019 - 2026 Chapter ## Methodology and Scope ##. ##.

  • Opioid
  • Therapy
  • United States
  • Forecast
  • Market Size

2019 Future of Opioid/ Opium Addiction R& D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments ##.

  • Opioid
  • Therapy
  • ADVICE FOR THE TECHNOLOGY BUYER
  • Data Access and Sharing

IDC ANALYZE THE FUTURE IDC PERSPECTIVE Adelaide O' Brien EXECUTIVE SNAPSHOT FIGURE ## Addiction Prevention and Monitoring: Leveraging DX to Tackle the Opioid Epidemic in Kentucky Executive Snapshot: Addiction Prevention and Monitoring - Leveraging DX to Tackle the

  • Advanced IT
  • Healthcare
  • Opioid
  • Therapy
  • United States

Global Market Study on Opioids: Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period ##.

  • Opioid
  • Therapy
  • APAC
  • World
  • Market Size

One of the major determinants is the growing geriatric population with clinically demonstrated susceptibility to terminal conditions, such as rheumatoid arthritis, is positively impacting this vertical.

  • Opioid
  • Therapy
  • North America
  • United States
  • Forecast
  • JUN 22, 2018: ANALYSIS OF INSURANCE COVERAGE FOR BACK PAIN SHOWS MISSED OPPORTUNITIES TO PRESCRIBE NON-OPIOID MEDICATIONS
  • DEC 20, 2017: SEVEN EMMES EMPLOYEES RECOGNIZED IN LANCET STUDY COMPARING TWO OPIOID TREATMENTS

" Opioid addiction has emerged as one of the most critical public health issues, said Dr.

  • Opioid
  • Therapy
  • United States
  • Lightlake Therapeutics Inc.
  • Opiant Pharmaceuticals, Inc.

Chapter ## – Executive Summary The report commences with an executive summary of the oxycodone market report, which includes the summary of key findings and key statistics.

  • Opioid
  • North America
  • World
  • Forecast
  • Market Size
  • OPIOID PRESCRIPTIONS
  • ADVANCES IN OPIOID RECEPTOR RESEARCH

BUNAVAIL CONTAINS BUPRENORPHINE HCL, A MU--OPIOID RECEPTOR PARTIAL AGONIST AND A KAPPA--OPIOID RECEPTOR ANTAGONIST, AND NALOXONE HCL DIHYDRATE, AN OPIOID RECEPTOR ANTAGONIST, AT A RATIO OF ~##:## (RATIO OF FREE BASES).

  • Opioid
  • Actavis plc
  • Bedrocan Canada Inc.
  • Insys Therapeutics, Inc.
  • Medical Marijuana, Inc.
  • NON-GOVERNMENT INSTITUTIONS INITIATIVES
  • 9.4 INCREASED PRODUCTION AND TRAFFICKING OF ILLEGAL DRUGS

The overdose of opioids results in adverse and serious health conditions.

  • Opioid
  • World
  • Forecast
  • Alere Inc.
  • Danaher Corporation
  • 3. Opioid Dependence Market
  • 1.5 OPIOIDS OVERVIEW

In the U. S., there are indications of a partial shift in the use of opioids towards heroin, attributable in the part to changes in the formulation of OxyContin, which is one of the main prescription opioids to be misused.

  • Opioid
  • United States
  • Egalet Corporation
  • Pfizer Inc.
  • Purdue Pharma L.P.
  • Opioids
  • Opioids

You can easily book an appointment with one online.

  • Opioid
  • Market Size
  • BioDelivery Sciences International, Inc.
  • ProStrakan Group plc
  • Teva Pharmaceuticals Ltd.
  • 3.2 Opioid Sales in US Chronic Pain Market - Forecast: Sizing &
  • 3.1 Opioid Sales in US Chronic Pain Market: Sizing & Growth

The US Chronic Pain Market - Focus on Opioids: Trends & Opportunities (2014-##) November 2014 Daedal Research List of Figures and Tables ##.

  • Opioid
  • United States
  • Egalet Corporation
  • Pfizer Inc.
  • Zogenix, Inc.
  • Opium (Opioid) Addiction - Therapeutics Assessment
  • Opium (Opioid) Addiction - Drug Profiles

Opium (Opioid) Addiction - Overview Opium (Opioid) Addiction - Therapeutics Development NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR OPIUM (OPIOID) ADDICTION, H## 2018 PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR OPIUM (OPIOID) ADDICTION, H## 2018 Pre-Regi

  • Opioid
  • Therapy
  • United States
  • Product Initiative
  • Addex Therapeutics Ltd
  • Opioid-Induced Constipation (OIC) - Product Development Milestones
  • Opioid-Induced Constipation (OIC) - Therapeutics Assessment

The molecules developed by Companies in Pre-Registration, Phase III and Phase II stages are ##, ## and ## respectively.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Opioid
  • United States
  • Product Initiative
  • Revenue of Key Products in Opioid Category 2016- 2018
  • Opioids Market: Revenue Share (% ), by Country, Europe, 2018

Opioids have been regarded as one of the most effective drugs for the treatment of pain.

  • Opioid
  • North America
  • United States
  • World
  • Market Size

Since the availability of ADF opioids have you become more reluctant to prescribe generic opioids which do not have an ADF?

  • Opioid
  • Pharmaceutical
  • Therapy
  • United States
  • Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) - Discontinued Products
  • Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) - Product Development Milestones

It binds to opioid receptor like ## (ORL-##, NOC-##) receptor.

  • Opioid
  • Therapy
  • United States
  • World
  • Product Initiative
  • Opioid-Induced Constipation (OIC) - Therapeutics Assessment
  • Opioid-Induced Constipation (OIC) - Product Development Milestones

All doses were safe and well tolerated with only four serious adverse events reported (## for placebo, ## for the ##. ## mg and ## for the ##. ## mg dose groups).

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Opioid
  • United States
  • Product Initiative